Hospital Copa D'or

Rio de Janeiro CEP: 22031-010

0 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Crohn Disease, Myocardial Infarction, Stroke

Studies at this site

• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed